Company intelligence / Profile preview

Dialyss

Singapore, Central Region, Singapore

Ownership: Private
Development stage: Other

Overview

Dialyss was a Singapore-based medtech company focused on sorbent-based regeneration of dialysate for home hemodialysis applications. Its core technology was designed to enable low-volume, portable dialysis systems by regenerating spent dialysate, a key component for next-generation home and wearable kidney replacement devices. The company collaborated with NextKidney for several years before being fully acquired by NextKidney effective January 1, 2022. Following the acquisition, Dialyss appears to have been integrated into NextKidney's portable hemodialysis development efforts rather than continuing as an independent operating company.

Therapeutic areas: Nephrology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

NextKidney

Beyond the preview

Go deeper on Dialyss.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dialyss.

Explore the full profile